We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Better DNA Microarray Analysis

By Biotechdaily staff writers
Posted on 03 Jan 2006
A new method that blends experiment and computation makes DNA microarray analysis more sensitive and specific, promising to improve research on diseases.

DNA microarray identifies gene activation in living, complex biologic systems. More...
It monitors the behavior of thousands of genes over time by detecting changes in the expression of as many as 30,000 different genes on one small chip. The technique has been used to study some of the most important biologic systems, including how cells divide and immune responses to disease and infection.

The new procedure is based on a "check-sum” protocol initially developed to ensure that e-mail messages did not become garbled in transmission. In standard Internet protocol, bits of information that begin as one value (0 or 1) may flip to the opposite value as they move from one computer to the next via e-mail. This data loss is checked by counting the number of ones in the message. If this number is odd, then the last bit is set to one; otherwise, it is set to zero. By comparing the last bit on the receiving end, the recipient's computer can tell whether the message was accurately received. If not, the recipient's computer asks the sender's computer to forward the message again.

The new DNA microarray method carries out a similar analysis of the microarray snapshots by checking the sum of a set of DNA microarray data points over time against the summary of the temporal response. If the two sets of results are equal, then what is captured by the microarray time series is real. If the time series results produce a lower value than the microarray summary, the protocol indicates that the researchers have missed a gene's activation somewhere in their time series.

Just as important is whether a DNA microarray summary value exceeds its time sequence value. If that happens, then researchers have likely identified gene activity that should be attributed to changes taking place during an experiment, such as adding a chemical or changing the temperature. This part of the method provides the specificity required to weed out such introduced gene activation from gene activation pathways that form the hallmark of processes such as cancer or immunity.

The new DNA microarray method was developed by Ziv Bar-Joseph, assistant professor of computer science and biologic sciences at Carnegie Mellon University (Pittsburgh, PA, USA), together with collaborators at the Hebrew University (Jerusalem, Israel). Their work was described in the December 2005 issue of Nature Biotechnology.

To prove the effectiveness of their method, Dr. Bar-Joseph studied the human cell division cycle, which plays a major role in cancer. He and his colleagues identified many new human genes that were not previously found to be participants in this system. The new method also overcomes synchronization loss, which occurs as groups of cells become asynchronized in their activities.

"We are very excited about introducing this versatile, powerful method to the research community because it can be used to study a wide range of complex, dynamic systems more comprehensively,” observed Dr. Bar-Joseph. "Such systems under study include stress and drug response, cancer, and embryo development.”




Related Links:
Carnegie Mellon U.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.